Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
454.50
Change Change %
-8.70 -1.88%

Updated:22 Apr, 2019, 15:57 PM IST

BSE
454.50
Change Change %
-7.60 -1.64%

Updated:22 Apr, 2019, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Religare
N/A
21-03-2014 Buy 585.00 740.00
N/A
Target Hit Long (1Y)
21-03-2015

Religare maintains buy on Sun Pharma

Stock correction is overdone. Expect strong guidance by Sun post Q4. New competitor in Doxil is at least a year away. Valuations reasonable post correction. 

Top